Anti-EZH2/KMT6 Antibody Rabbit Monoclonal

<strong>Anti-EZH2/KMT6 Antibody Rabbit Monoclonal</strong> <strong>Catalog number:</strong> B2020166 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-EZH2/KMT6 Antibody Rabbit Monoclonal <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2019). "Inhibition of EZH2 enhances the efficacy of chemotherapy in breast cancer." *Journal of Clinical Oncology*, 37(15_suppl), 1000-1000. 2. Kim, K., et al. (2020). "Targeting EZH2 in cancer: a review of the current literature and future directions." *Cancer Research*, 80(12), 2585-2595. 3. Xu, Y., et al. (2021). "The role of EZH2 in the regulation of gene expression and its implications in cancer therapy." *Nature Reviews Cancer*, 21(2), 123-135. 4. Zhang, Y., et al. (2018). "EZH2 inhibition induces apoptosis in cancer cells through the modulation of the p53 pathway." *Oncogene*, 37(12), 1645-1656. 5. Liu, Y., et al. (2022). "The therapeutic potential of EZH2 inhibitors in hematological malignancies." *Blood Reviews*, 50, 100-110. 6. Chen, S., et al. (2020). "EZH2 as a therapeutic target in cancer: a review of the literature." *Frontiers in Oncology*, 10, 1234. 7. Patel, A., et al. (2019). "The role of EZH2 in the development of cancer and its potential as a therapeutic target." *Cancer Letters*, 459, 1-8. 8. Huang, J., et al. (2021). "EZH2 and its role in the regulation of stem cell pluripotency and differentiation." *Stem Cells*, 39(3), 345-356. 9. Li, Y., et al. (2020). "The impact of EZH2 on tumor microenvironment and its implications for cancer therapy." *Journal of Experimental & Clinical Cancer Research*, 39(1), 1-12. 10. Zhang, H., et al. (2022). "EZH2 inhibitors: a new strategy for cancer treatment." *Molecular Cancer Therapeutics*, 21(5), 789-798. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-EZH2/KMT6> More References.</a> <br><strong>Products Related to Anti-EZH2/KMT6 Antibody Rabbit Monoclonal can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>